Αποτελέσματα Αναζήτησης
Non-small cell lung cancer (NSCLC) treatment options include surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy. Laser therapy, photodynamic therapy, cryosurgery, and electrocautery may be used. Learn more about NSCLC in this expert-reviewed summary.
- Small Cell Lung Cancer Treatment
Small cell carcinoma (also called oat cell cancer) is a type...
- Small Cell Lung Cancer Treatment
2 Σεπ 2022 · The use of positron emission tomography (PET) could increase the proportion of patients in whom lung cancer is diagnosed in the early stages and thereby reduce lung cancer mortality. The problem is how to increase the number of patients who undergo PET.
11 Αυγ 2023 · Targeted drugs are often used for advanced lung cancers when conventional drugs don't affect them, mainly because they have different side effects. Many drugs targeting these pathways have been developed, and there are numerous FDA-approved targeted agents [ 5 ].
24 Σεπ 2024 · This page lists cancer drugs approved by the Food and Drug Administration (FDA) for lung cancer. The list includes generic names, brand names, and common drug combinations, which are shown in capital letters.
The panel has updated the list of recommended targeted therapies based on recent FDA approvals and clinical data. This selection from the NCCN Guidelines for NSCLC focuses on treatment recommendations for advanced or metastatic NSCLC with actionable molecular biomarkers.
14 Ιουλ 2021 · This Seminar provides an overview of advances in the screening, diagnosis, and treatment of non-small-cell lung cancer (NSCLC) and small-cell lung cancer (SCLC), with a particular focus on targeted therapies and immune checkpoint inhibitors (ICIs).
Abstract. Lung cancer accounts for most cancer-related deaths worldwide and has an overall 5-year survival rate of ~15%. Cell lines have played important roles in the study of cancer biology and potential therapeutic targets, as well as pre-clinical testing of novel drugs. However, most experimental therapies that have cleared preclinical ...
